Hämo Pharma announces Partnership with Austria's Record Sprinter Markus Fuchs

Record holder Markus Fuchs‍

Markus Fuchs has made a name for himself as an outstanding athlete and record holder on the 100-meter track by running this distance in an impressive 10.08 seconds. For him, this is just the beginning: Markus strives for new top performances and has a clear goal in mind - Be the first Austrian to run the 100 meters in under 10 seconds.

Markus relies on the partnership with Haemo Pharma to achieve this ambitious goal. In addition to financial support and medical care, the family-owned company also offers innovative technologies. With the ultra-modern WINBACK electrotherapy device Markus can optimize his performance and shorten his regeneration phases: “When sprinting, small but important details play a decisive role on the path to perfection — rapid regeneration and optimal preparation are of paramount importance. Through the partnership with Haemo Pharma, I not only have a strong partner at my side, but also the mental security of having a reliable contact,” he emphasizes.

Managing Director Mag. Markus Mateyka is fully committed to Austria's fastest runner: “The partnership with Markus is an expression of our vision that passion and tireless commitment are the basis for outstanding performance. His quest for new top performances and his clear goal of being the first Austrian to run 100 meters in under 10 seconds reflect the values that we maintain at Hämo Pharma: Determination, Innovation, and Pursuit of Excellence. ”

Succeed with WINBACK‍

The versatile WINBACK therapy device uses various types of electricity, such as TECAR, hi-EMS and hi-TENS, which enable highly effective tissue stimulation and raise muscle and tendon regeneration to a new level. Both athletes and recreational athletes can benefit from faster healing times, reduced inflammation, and improved flexibility. With WINBACK, athletes can exceed their limits and take their success to the next level.
WINBACK therapy is already an integral part of the training plans of leading international sports clubs such as Paris Saint Germain, FC Bayern Munich, Liverpool FC, Red Bull Cliff Diving and New York Jets Football, and many other institutions worldwide.

Shared passion - In the fast lane of running‍

Running plays a special role for the family-owned company Haemo Pharma. In 1977, Prof. Dr. Mateyka, owner of Hämo Pharma, broke several Austrian records with peak times of 33.3 seconds over 300 meters and 21.33 seconds over 200 meters. Two years later, with a time of 46.89 seconds over 400 meters, he secured the title as the fastest man in Austria. Accordingly, he is familiar with the challenges that a sports career entails:

“As a former professional athlete, I am now confronted with the long-term consequences of competitive sport. In the 1970s, we did not have the innovative treatment methods available today. For this reason, maintaining the joints of young athletes in Austria is particularly important to me,” says Prof. Dr. Peter Mateyka.

About Haemo Pharma‍

Hämo Pharma GmbH was founded in 2006 by Prof. Dr. Peter Mateyka and Mag. Markus Mateyka to improve the quality of life through innovative products. As a pharmaceutical and medical device wholesaler, the family-owned company focuses on high-quality original products in the core areas of orthopedics, traumatology, physiotherapy and gastroenterology. In the orthopedic sector in particular, the focus is on regenerative medicine and long-term joint maintenance. Since 2018, Haemo Pharma has been a tissue bank and
Tissue collection facility certified.‍